ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial
08 mars 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics to Present at the XXVth Biennial Meeting of the International Society for Eye Research
13 févr. 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics to Present at 2023 BIO CEO & Investor Conference
02 févr. 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for ONL1204 Ophthalmic Solution
01 févr. 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 01, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Lumotive and Lumentum Introduce Innovative Reference Design to Enable Faster Adoption of Next-Generation 3D LiDAR Solutions
30 janv. 2023 10h00 HE
|
Lumotive
SEATTLE and SAN JOSE, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Lumotive, the developer of Light Control Metasurface (LCM™) beam steering chips enabling the next generation of 3D sensors, and Lumentum...
ONL Therapeutics to Highlight New Data in Upcoming Scientific Presentations at the 46th Annual Macula Society Meeting and the XXVth Biennial Meeting of the International Society for Eye Research
26 janv. 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Percept Corporation Names Vision Industry Leader Jim McGrann as President and Chief Operating Officer
16 janv. 2023 07h30 HE
|
Percept
LAS VEGAS, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Percept Corporation, a developer of eye tracking, eye control, and perceptual optimization technology for the global vision industry, is pleased to...
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
24 oct. 2022 13h05 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to...
Orange County Vision Center Announces Grand Opening of New Location
11 oct. 2022 09h22 HE
|
Orange County Vision Center
GARDEN GROVE, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orange County Vision Center is excited to announce the grand opening of a new location in Garden Grove, CA! The new office is spacious and...
Vision Care Market Size Worth USD 237 Billion by 2030 at 4.03% CAGR - Report by Market Research Future (MRFR)
11 août 2022 04h30 HE
|
Market Research Future
New York, USA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vision Care Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vision Care Market Information By...